Mariana Chávez‐MacGregor

Author

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

Amalado, Chavez Mac Gregor, M, Chavez-MacGregor M, M Chavez Mac Gregor, M Chavez Mac-Gregor, M Chavez-Mac-Gregor, M Chavez-MacGregor, M Chavez-Macgregor, M Gregor, M. Chavez Mac Gregor

344

Publications

14K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Dana-Farber Cancer Institute American Society of Clinical Oncology Harvard University Breast Cancer Care

About

Mariana Chávez‐MacGregor is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	36	2.4K
2	Health Sciences	7	7	554
3	Nursing	3	3	219
4	Engineering	2	2	57
5	Management	1	1	49

Mariana Chávez‐MacGregor

111

Publications

10.6K

Citations

H-Index

Page 1

	Year	Citations
Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update Kimberly H. Allison, M. Elizabeth H. Hammond, Mitch Dowsett, Journal of Clinical Oncology	2020	1.4K
Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection Abigail S. Caudle, Wei Yang, Savitri Krishnamurthy, Journal of Clinical Oncology	2016	860
Beta-Blocker Use Is Associated With Improved Relapse-Free Survival in Patients With Triple-Negative Breast Cancer Amal Melhem‐Bertrandt, Mariana Chávez‐MacGregor, Xiudong Lei, Journal of Clinical Oncology	2011	449
Delayed Initiation of Adjuvant Chemotherapy Among Patients With Breast Cancer Mariana Chávez‐MacGregor, Christina A. Clarke, Daphne Y. Lichtensztajn, JAMA Oncology	2015	362
Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline Update Kimberly H. Allison, M. Elizabeth H. Hammond, Mitch Dowsett, Archives of Pathology & Laboratory Medicine	2020	351
Clinical Impact of Delaying Initiation of Adjuvant Chemotherapy in Patients With Breast Cancer Débora De Melo Gagliato, Ana M. González-Angulo, Xiudong Lei, Journal of Clinical Oncology	2014	278
Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial Rebecca Aft, Michael Naughton, Kathryn Trinkaus, The Lancet Oncology Zoledronic AcidBreast OncologyOpen LabelMedicinePharmacology	2010	270
Management of the Axilla in Early-Stage Breast Cancer: Ontario Health (Cancer Care Ontario) and ASCO Guideline Muriel Brackstone, Fulvia Baldassarre, Francisco Perera, Journal of Clinical Oncology	2021	269
Trastuzumab-Related Cardiotoxicity Among Older Patients With Breast Cancer Mariana Chávez‐MacGregor, Ning Zhang, Thomas A. Buchholz, Journal of Clinical Oncology	2013	238
Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation Yan Xing, Nancy U. Lin, Matthew Maurer, Breast Cancer Research	2019	225

Page 1